TriloTalk

Everyone is talking about “one-click AI,” but is it real or just a conference buzzword? In this episode of TriloTalk, Lisa Chamberlain James, Senior Partner at Trilogy, and Vladimir Penkrat, Associate VP Regulatory Affairs at Indegene, cut through the hype and explore what AI can actually do today in medical writing and regulatory affairs, where the biggest gaps are, and how organizations can actually make real progress.

This episode of TriloTalk explores companion diagnostics and what makes them medical devices. Join Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca and learn how in vitro diagnostic tools help pair the right treatment with the right patient and why we can’t just test drugs and their companion devices all in one go. Tune in!

Humans communicate through stories and medical writers help teams crystallize the story out of the data: this is the essence of what they bring to the table. Join Julia Forjanic Klapproth, Senior Partner at Trilogy Writing & Consulting, and Eleanor Steele, a freelance consultant working as the Med Comms Mentor, for TriloTalk episode 39 where they explore the power of storytelling in medical writing and explain the PRISM framework, which is a useful system for medical writers to make each story hit the mark.

For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, talk about how to use AI in the creation of lay summaries of clinical trial results. Scalability, change management, prompting, biases, realistic attitudes, and human involvement are all touched on so listen up!

TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices. Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca, talk about this and what medical writers need to understand when crafting these regulatory documents.